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Background
The most useful model system for HIV vaccines is SIV
infection of non-human primates (typically rhesus
macaques). The pathogenic SIV strains in common use
were derived from macaques infected in captivity by
viruses originally from sooty mangabeys. In the course of
developing new viral stocks and vaccine antigens for chal-
lenge studies, we investigated the mode of evolution in
natural SIV isolates from sooty mangabeys, comparing it
to that of HIV-1 isolates from the global pandemic.
Methods
We assembled a diverse SIV set comprising sooty manga-
bey SIV (SIVsmm) whole-genome sequences from pub-
lished and unpublished sources, including novel
sequences; all sequences were either directly isolated or
minimally passaged. Diversity-matched HIV-1 data sets
were constructed for HIV-1 M-group sequences for four
vaccine candidate genes, Gag, Pol, Env, and Nef. We con-
structed phylogenetic trees, and calculated substitution
rate ratios to infer selective pressure upon the two differ-
ent viruses in the two different primate hosts.
Results
The ratios of synonymous to non-synonymous substitu-
tions (Dn/Ds) for Gag, Pol, Env, and Nef) were 1.4 to 2.0
times higher for HIV-1 than for the SIVsmm. The greatest
disparities were observed in HIV-1 Gag and Pol. In both
these genes, SIVsmm and HIV-1 have similar numbers of
amino-acid changes, but SIVsmm has a higher number of
synonymous substitutions. In constrast, non-synony-
mous substitutions are elevated in HIV-1 Env relative to
SIVsmm, and HIV-1 Nef has a higher rate of both synony-
mous and non-synonymous substitutions.
Conclusion
HIV-1 in humans is under stronger diversifying selection
in general than is SIVsmm in sooty mangabeys. This dispar-
ity is strikingly pronounced in Env, possibly due to greater
immune pressure in humans this has implications for
studying the impact of vaccine-elicited immune responses
on pathogenesis and protection, and the relevance of
macaque vaccine studies to humans.
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